Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| DEXCOM INC | 51,382 | reported | 16 Jul 2018 | tx 545+4,923,583−4,408,713 |
| AMYLIN PHARMACEUTICALS INC | 3,440 | reported | 05 Apr 2006 | tx 16+17,995 |
| OCULAR SCIENCES INC /DE/ | 567.277 | reported | 01 Apr 2004 | tx 2+567.277 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Jul 2018 | SALE | DEXCOM INC | 500 | 100.73 USD | |
| 16 Jul 2018 | SALE | DEXCOM INC | 5,600 | 99.23 USD | |
| 16 Jul 2018 | SALE | DEXCOM INC | 3,900 | 99.87 USD | |
| 15 Jun 2018 | SALE | DEXCOM INC | 10,000 | 97.81 USD | |
| 15 May 2018 | SALE | DEXCOM INC | 10,000 | 85.90 USD | |
| 16 Apr 2018 | SALE | DEXCOM INC | 10,000 | 73.04 USD | |
| 15 Mar 2018 | SALE | DEXCOM INC | 10,000 | 65.51 USD | |
| 12 Mar 2018 | OTHER | DEXCOM INC | 9,972 | 60.73 USD | |
| 08 Mar 2018 | GRANT_AWARD | DEXCOM INC | 47,087 | 0.00 USD | |
| 15 Feb 2018 | SALE | DEXCOM INC | 10,000 | 55.91 USD | |
| 16 Jan 2018 | SALE | DEXCOM INC | 10,000 | 56.86 USD | |
| 24 May 2017 | EXERCISE | DEXCOM INC | 30,000 | 6.85 USD | |
| 24 May 2017 | EXERCISE | DEXCOM INC | 30,000 | 0.00 USD | deriv |
| 20 Apr 2017 | SALE | DEXCOM INC | 15,000 | 74.10 USD | |
| 08 Mar 2017 | GRANT_AWARD | DEXCOM INC | 30,887 | 0.00 USD | |
| 10 Mar 2017 | OTHER | DEXCOM INC | 1,661 | 77.55 USD | |
| 10 Mar 2017 | OTHER | DEXCOM INC | 14,512 | 77.55 USD | |
| 09 Feb 2017 | OTHER | DEXCOM INC | 1,421 | 79.35 USD | |
| 09 Jan 2017 | OTHER | DEXCOM INC | 1,511 | 63.50 USD | |
| 15 Dec 2016 | GIFT | DEXCOM INC | 10,000 | 0.00 USD | |
| 09 Dec 2016 | OTHER | DEXCOM INC | 2,167 | 64.46 USD | |
| 09 Nov 2016 | OTHER | DEXCOM INC | 2,172 | 62.17 USD | |
| 10 Oct 2016 | OTHER | DEXCOM INC | 2,167 | 83.35 USD | |
| 09 Sept 2016 | OTHER | DEXCOM INC | 2,203 | 93.72 USD | |
| 07 Sept 2016 | SALE | DEXCOM INC | 5,595 | 95.01 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Mar 2008.